Following up on the success of “Building Biotechnology” (www.BuildingBiotechnology.com), I’m in the late stages of assembling a more advanced follow-up book featuring articles from industry insiders with deep experience.
Join a dozen other industry insiders writing about topics in:
- Business Planning
- Intellectual Property
- Licensing and technology transfer
- Public Relations
Further details available upon request. If you are interested, please respond using the contact form.
Courtesy of DrugPatentWatch.com:
Drug Patent Expirations in April 2007
*Drugs may be covered by more than one patent
Courtesy of DrugPatentWatch.com
Genentech is investing $140mm in a new biologic manufacturing plant in Singapore. The first commercial-scale microbial fermentation plant in Singapore, and a significant International investment by US-based Genentech. This is the latest of a number of international manufacturing and R&D centers being located in Singapore, and is a sign of the growing trend of biotechnology operations being globally distributed in specialized centers with favorable economics, worker, or other resource availability.
In a related post, David Rosen reports that Indian trade possibilities boggle the mind while on an Illinois trade mission to India.